2015•Journal of Pediatric NeurologyRequires access

Sumatriptan formulated with RT technology™ as early intervention for migraine in adolescents

Paul K Winner

Open publisher page 1 citations

Abstract

To assess the feasibility, efficacy, and tolerability of early intervention with sumatriptan tablets formulated with RT Technology™ (sumatriptan RT) for adolescent migraine. Conventional triptan tablets, a treatment of choice for migraine in adults,

About this research paper

What this paper is about

To assess the feasibility, efficacy, and tolerability of early intervention with sumatriptan tablets formulated with RT Technology™ (sumatriptan RT) for adolescent migraine. Conventional triptan tablets, a treatment of choice for migraine in adults,

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To assess the feasibility, efficacy, and tolerability of early intervention with sumatriptan tablets formulated with RT Technology™ (sumatriptan RT) for adolescent migraine. Conventional triptan tablets, a treatment of choice for migraine in adults,

Key concepts: Sumatriptan, Medicine, Migraine, Intervention (counseling), Migraine Disorders, Psychiatry, Internal medicine, Agonist

Related papers

Back to paper searchBrowse research topicsOriginal source
Sumatriptan formulated with RT technology™ as early intervention for migraine in adolescents — Research Paper | ScholarLens